Caplight Directory>Companies>Polku Therapeutics-preview>Polku-therapeutics


Polku Therapeutics

Polku Therapeutics

Private
HelsinkiHealthcare & Life Scienceshttps://polku-therapeutics.com

Last Round

Grant

Jan 31, 2025

Total Funding Raised

$2.67M

Company Overview

Polku Therapeutics is a biotechnology company that develops innovative therapies for neurodegenerative diseases, such as Parkinson's disease and Alzheimer's disease.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Clinical Trials

Business Model

B2B

Customer Profile

Revenue Share, Government Contracts

AI Layer

Non-AI

Keywords

small molecule therapeuticsPREP ligandsneurodegenerative diseasedisease-modifying therapyParkinson's diseaseAlzheimer's diseasePREP enzyme targetvirtual drug developmentvirtual biotechpreclinical drug developmenttauopathiespharma licensingneuroinflammationprotein aggregationuniversity spin-outCRO network

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Polku Therapeutics Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Polku Therapeutics Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
GrantJan 31, 2025
Pre SeedSep 17, 2024
View all Funding Rounds

Polku Therapeutics Investors

Notable investors and investment history

InvestorRounds
InnovestorPre Seed
Rainwater Charitable FoundationGrant
Business FinlandPre Seed
Alzheimer's AssociationGrant
Alzheimer's Drug Discovery FoundationGrant
View all Investors

Polku Therapeutics Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Polku Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Polku Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersHelsinki
Employee Range5
Year Founded2023
Last FundingJan 31, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.